{"id":"W4385760516","doi":"10.1016/j.medj.2023.07.006","title":"A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials","year":2023,"lang":"en","type":"article","venue":"Med","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vector Institute; Ontario Institute for Cancer Research; Université de Montréal; University of Toronto; University Health Network; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"Sociedad Española de Oncología Médica; Generalitat de Catalunya; Fundación Fero; Princess Margaret Cancer Foundation; Agencia Estatal de Investigación; Fundación Cellex; Fundación BBVA","keywords":"Immunotherapy; Medicine; Oncology; Clinical trial; Tumor microenvironment; Internal medicine; Cancer; Biomarker; Cohort; Cancer immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007405699,0.0007075462,0.001251771,0.002228991,0.0002581356,0.00149931,0.0007586635,0.00052371,0.006006892],"category_scores_gemma":[0.0103149,0.0003118443,0.0008741457,0.001325935,0.0002506545,0.000845127,0.001449994,0.0008647763,0.001359747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000926274,"about_ca_system_score_gemma":0.001734264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004451463,"about_ca_topic_score_gemma":0.001433695,"domain_scores_codex":[0.9969625,0.001472754,0.0003123762,0.0006056361,0.0004912211,0.000155639],"domain_scores_gemma":[0.9913055,0.003935026,0.002559552,0.0005546797,0.0009906972,0.0006546529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01406481,0.0007720157,0.3926131,0.002514778,0.002849626,0.0003270136,0.000236737,0.0273009,0.02672641,0.003488727,0.05887775,0.4702281],"study_design_scores_gemma":[0.004940049,0.009054649,0.4651093,0.00120358,0.005388065,0.001811027,0.0003440391,0.2503438,0.05598487,0.02720852,0.1782942,0.0003178308],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6318348,0.02338266,0.1940114,0.01026898,0.0008647476,0.004827284,0.09365221,0.01801686,0.02314107],"genre_scores_gemma":[0.7978121,0.002175238,0.1504736,0.003224561,0.0004910167,0.003825561,0.03826307,0.000472825,0.003262093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007405699,"threshold_uncertainty_score":0.03916556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1287103824566079,"score_gpt":0.4795920880734986,"score_spread":0.3508817056168906,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}